Announcement on holding the results briefing for the third quarter of 2024
Shengnuo Biotech: Opinions of Minsheng Securities Co., Ltd. on the verification opinion of Chengdu Shengnuo Biotechnology Co., Ltd. on increasing the amount of daily related transactions expected in 2024
Shengnuo Biotech: Announcement on increasing the amount of daily related transactions expected in 2024
Shengnuo Biopharmaceutical Co., Ltd.: Basic information on Chengdu Shengnuo Biopharmaceutical Co., Ltd. and financial statements of June 30, 2024
Shengnuo Biotech: Announcement on the company increasing the guarantee amount for its wholly-owned subsidiary to apply for comprehensive bank credit in 2024
Shengnuo Biotech: Minsheng Securities Co., Ltd.\'s inspection opinion on the extension of some fund-raising investment projects of Chengdu Shengnuo Biotechnology Co., Ltd.
Shengnuo Biotech: Announcement of Resolutions of the 22nd Meeting of the 4th Board of Supervisors
Shengnuo Biotech: Opinions of Minsheng Securities Co., Ltd. on the verification of Chengdu Shengnuo Biotechnology Co., Ltd. to increase the guarantee amount for a wholly-owned subsidiary to apply for comprehensive bank credit in 2024
Opinions of Minsheng Securities Co., Ltd. on the verification of Chengdu Shengnuo Biotechnology Co., Ltd. to increase the guarantee amount for its wholly-owned subsidiary to apply for comprehensive bank credit in 2024
Opinions of Minsheng Securities Co., Ltd. on the verification opinion of Chengdu Shengnuo Biotechnology Co., Ltd. on increasing the amount of daily related transactions expected in 2024
Announcement on increasing the estimated daily related transaction quota for 2024
Verification opinion of Minsheng Securities Co., Ltd. on the extension of some fund-raising investment projects of Chengdu Shengnuo Biotechnology Co., Ltd.
Announcement of Resolutions of the 22nd Meeting of the Fourth Board of Supervisors
Reply to the “Inquiry Letter on Serious Abnormal Fluctuations in the Stock Trading of Chengdu Shengnuo Biotechnology Co., Ltd.”
Notice of Serious Unusual Fluctuations in Stock Trading
Minsheng Securities Co., Ltd.'s continuous supervision and follow-up report on the Chengdu Shengnuo Biotechnology Co., Ltd.'s 2024 semi-annual report.
Chengdu Shengnuo Biotechnology Co., Ltd. Investor Relations Activity Record Form 2024-03
Investor relations activity record of Chengdu Shengnuo Biotechnology Co., Ltd. 2024-02
Announcement Regarding the Holding of the 2024 Semi-Annual Performance Briefing.
Semi-annual evaluation report on the special action plan for quality improvement and efficiency increase of the company's return in 2024.
No Data
No Data